Dow 
1.48% Nasdaq 1.73%
1.48% Nasdaq 1.73%Nov 27: 1.85 
0.12 (6.94%)
0.12 (6.94%) Pharmacyclics Inc. (PCYC)
Compare PCYC to:
- Dow Jones (^DJI)
- NASDAQ (^IXIC)
- S&P 500 (^GSPC)
Pharmacyclics, Inc.
(NasdaqCM: PCYC)After Hours: 0.00 N/A (N/A) 7:00pm ET
| Last Trade: | 1.85 |
|---|---|
| Trade Time: | Nov 27 |
| Change: | 0.12 (6.94%) |
| Prev Close: | 1.73 |
| Open: | 1.72 |
| Bid: | 1.78 x 100 |
| Ask: | N/A |
| 1y Target Est: | 2.00 |
| Day's Range: | 1.71 - 1.85 |
|---|---|
| 52wk Range: | 0.57 - 2.41 |
| Volume: | 9,831 |
| Avg Vol (3m): | 70,764.6 |
| Market Cap: | 92.63M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.72 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. For consolidated real-time quotes (incl. pre/post market data), sign up for a free trial of Real-time Quotes.
Headlines
| Thu, Nov 12 | PHARMACYCLICS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online |
| Thu, Nov 12 | Pharmacyclics Announces Poster Presentations and Clinical Update at the 51st Annual Meeting of the American Society of HematologyPR Newswire |
| Mon, Nov 9 | Pharmacyclics to Present at Merriman Curhan Ford's Investor Summit 2009PR Newswire |
| Tue, Nov 3 | PHARMACYCLICS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online |
| Mon, Nov 2 | CEO Interview: Provectus Pharmaceuticals, Inc. - Peter R. CulpepperWall Street Transcript |
| Mon, Nov 2 | PHARMACYCLICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitEDGAR Online |
| Thu, Oct 29 | Pharmacyclics Reports First Quarter Fiscal 2010 Financial ResultsPR Newswire |
| Sat, Sep 26 | PHARMACYCLICS INC FinancialsEDGAR Online Financials |
| Tue, Sep 22 | PHARMACYCLICS INC Files SEC form 10-K, Annual ReportEDGAR Online |
| Sat, Sep 19 | New Star Analyst Rankings for Pharmacyclics, Inc.StarMine |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.